Back
Eagle Pharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
28
EGRX
Eagle Pharmaceuticals
Last Price:
0.95
Seasonality Move:
11.29%
Sell
32
VRCA
Verrica Pharmaceuticals
Last Price:
1.00
Seasonality Move:
50.53%
Sell
28
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy, Sell or Hold?
- The current Eagle Pharmaceuticals [EGRX] share price is $0.95. The Score for EGRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- EGRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $0.99. The Score for VRCA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGRX Stock Price Chart
What is Eagle Pharmaceuticals's stock price today?
-
The Eagle Pharmaceuticals share price today is $0.95
The current trend is relatively stagnant and EGRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.99
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.
EGRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 49.76 | Sell |
| Chaikin Money Flow: | 12004 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.86) | Buy |
| Bollinger Bands (100): | (1.26 - 5.28) | Sell |
VRCA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 42.74 | Sell |
| Chaikin Money Flow: | 81325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.82 - 1.5) | Sell |
| Bollinger Bands (100): | (0.69 - 5.69) | Sell |
EGRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.77 | Buy |
| 20-day SMA: | 0.71 | Buy |
| 50-day SMA: | 1.63 | Sell |
| 200-day SMA: | 4.08 | Sell |
| 8-day EMA: | 0.81 | Buy |
| 20-day EMA: | 0.84 | Buy |
| 50-day EMA: | 1.58 | Sell |
| 200-day EMA: | 4.74 | Sell |
VRCA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.9 | Buy |
| 20-day SMA: | 1.07 | Sell |
| 50-day SMA: | 1.36 | Sell |
| 200-day SMA: | 5.01 | Sell |
| 8-day EMA: | 0.94 | Buy |
| 20-day EMA: | 1.05 | Sell |
| 50-day EMA: | 1.62 | Sell |
| 200-day EMA: | 3.98 | Sell |
Eagle Pharmaceuticals Earnings Growth & EGRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and an increase next year of $0.82 per share.
Eagle Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verrica Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||